Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Rimner

Showing results (181-190 of 272) with videos related to

Pageof 28
Sort By:
American Journal of Clinical Oncology|March 25, 2015
ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancerHenning Willers, Thomas E Stinchcombe, R Bryan Barriger, et al.
Oncology (Williston Park, N.Y.)|August 21, 2014
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intentJoe Yujiao Chang, Larry L Kestin, R Bryan Barriger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2021
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumabMaria Thor, Annemarie F Shepherd, Isabel Preeshagul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
Postoperative Radiation Therapy for Thymic Carcinoma: An Analysis of the International Thymic Malignancy Interest Group/European Society of Thoracic Surgeons DatabaseAndreas Rimner, Usman Ahmad, Stephanie M Lobaugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural MesotheliomaMarjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2023
Conventional and radiomic features to predict pathology in the preoperative assessment of anterior mediastinal massesMaria Mayoral, Andrew M Pagano, Jose Arimateia Batista Araujo-Filho, et al.
JAMA Network Open|January 5, 2023
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and DurvalumabEmily S Lebow, Annemarie Shepherd, Jordan E Eichholz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?Feng-Ming Spring Kong, Vitali Moiseenko, Jing Zhao, et al.
JCO Precision Oncology|May 1, 2024
Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS MetastasesKathryn R Tringale, Anna Skakodub, Jacklynn Egger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural MesotheliomaRitu R Gill, Anna K Nowak, Dorothy J Giroux, et al.
Pageof 28

Showing results (181-190 of 272) with videos related to

Sort By:
Pageof 28
American Journal of Clinical Oncology|March 25, 2015
ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancerHenning Willers, Thomas E Stinchcombe, R Bryan Barriger, et al.
Oncology (Williston Park, N.Y.)|August 21, 2014
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intentJoe Yujiao Chang, Larry L Kestin, R Bryan Barriger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2021
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumabMaria Thor, Annemarie F Shepherd, Isabel Preeshagul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
Postoperative Radiation Therapy for Thymic Carcinoma: An Analysis of the International Thymic Malignancy Interest Group/European Society of Thoracic Surgeons DatabaseAndreas Rimner, Usman Ahmad, Stephanie M Lobaugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural MesotheliomaMarjorie G Zauderer, Anne S Tsao, Tao Dao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2023
Conventional and radiomic features to predict pathology in the preoperative assessment of anterior mediastinal massesMaria Mayoral, Andrew M Pagano, Jose Arimateia Batista Araujo-Filho, et al.
JAMA Network Open|January 5, 2023
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and DurvalumabEmily S Lebow, Annemarie Shepherd, Jordan E Eichholz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?Feng-Ming Spring Kong, Vitali Moiseenko, Jing Zhao, et al.
JCO Precision Oncology|May 1, 2024
Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS MetastasesKathryn R Tringale, Anna Skakodub, Jacklynn Egger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural MesotheliomaRitu R Gill, Anna K Nowak, Dorothy J Giroux, et al.
Pageof 28